Meca-Lallana J, Ayuso T, Martinez-Yelamos S, Duran C, et al. Effectiveness of Fingolimod versus Natalizumab as Second-Line Therapy for
Relapsing-Remitting Multiple Sclerosis in Spain: Second-Line GATE Study. Eur Neurol 2020 Mar 18:1-9. doi: 10.1159/000505778.
PMID: 32187609